PubMed

ProCOC: the prostate cancer outcomes cohort study.

Umbehr M, Kessler TM, Sulser T, Kristiansen G, Probst N, Steurer J, Bachmann LM.

BMC Urol. 2008 Jun 17;8:9.PMID: 18559088 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review.

Sutcliffe P, Hummel S, Simpson E, Young T, Rees A, Wilkinson A, Hamdy F, Clarke N, Staffurth J.

Health Technol Assess. 2009 Jan;13(5):iii, xi-xiii 1-219. Review.PMID: 19128541 [PubMed - indexed for MEDLINE]Related articlesFree article

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.

Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward J, O'Connell DL, Armstrong BK.

BMJ. 2009 Nov 27;339:b4817. doi: 10.1136/bmj.b4817.PMID: 19945997 [PubMed - indexed for MEDLINE]Related articlesFree article

Quality of life after therapy for localized prostate cancer.

Penson DF.

Cancer J. 2007 Sep-Oct;13(5):318-26. Review.PMID: 17921731 [PubMed - indexed for MEDLINE]Related articles

Outcomes of localized prostate cancer following conservative management.

Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, Yao SL.

JAMA. 2009 Sep 16;302(11):1202-9.PMID: 19755699 [PubMed - indexed for MEDLINE]Related articles

Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice.

Litwin MS, Greenfield S, Elkin EP, Lubeck DP, Broering JM, Kaplan SH.

Cancer. 2007 May 1;109(9):1777-83.PMID: 17354226 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluating localized prostate cancer and identifying candidates for focal therapy.

Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT.

Urology. 2008 Dec;72(6 Suppl):S12-24.PMID: 19095124 [PubMed - indexed for MEDLINE]Related articles

Rationale and design of the National Program of Cancer Registries' Breast, Colon, and Prostate Cancer Patterns of Care Study.

McDavid K, Schymura MJ, Armstrong L, Santilli L, Schmidt B, Byers T, Steele CB, O'Connor L, Schlag NC, Roshala W, Darcy D, Matanoski G, Shen T, Bolick-Aldrich S; Breast, Colon and Prostate Cancer Data Quality and Patterns of Care Study Group.

Cancer Causes Control. 2004 Dec;15(10):1057-66.PMID: 15801489 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer 2004: insights from national disease registries.

Cooperberg MR, Park S, Carroll PR.

Oncology (Williston Park). 2004 Sep;18(10):1239-47; discussion 1248-50, 1256-8. Review.PMID: 15526829 [PubMed - indexed for MEDLINE]Related articles

Molecular markers and death from prostate cancer.

Concato J, Jain D, Uchio E, Risch H, Li WW, Wells CK.

Ann Intern Med. 2009 May 5;150(9):595-603.PMID: 19414838 [PubMed - indexed for MEDLINE]Related articlesFree article

Defining an international research agenda for quality of life in men with prostate cancer.

Litwin MS, Fitzpatrick JM, Fossa SD, Newling DW.

Prostate. 1999 Sep 15;41(1):58-67.PMID: 10440876 [PubMed - indexed for MEDLINE]Related articles

ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer.

Chambers SK, Ferguson M, Gardiner RA, Nicol D, Gordon L, Occhipinti S, Aitken J.

BMC Cancer. 2008 Jul 24;8:207.PMID: 18651985 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.

Cooperberg MR, Broering JM, Carroll PR.

J Natl Cancer Inst. 2009 Jun 16;101(12):878-87. Epub 2009 Jun 9.PMID: 19509351 [PubMed - indexed for MEDLINE]Related articles

Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.

Hegarty JM, Wallace M, Comber H.

Am J Mens Health. 2008 Jun;2(2):133-42. Epub 2007 May 23.PMID: 19477777 [PubMed - indexed for MEDLINE]Related articles

Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer.

Dandapani SV, Sanda MG.

Semin Radiat Oncol. 2008 Jan;18(1):67-72. Review.PMID: 18082590 [PubMed - indexed for MEDLINE]Related articles

Outcomes and follow-up strategies for patients on active surveillance.

Dall'Era MA, Carroll PR.

Curr Opin Urol. 2009 May;19(3):258-62. Review.PMID: 19295434 [PubMed - indexed for MEDLINE]Related articles

ICE COLD ERIC--International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts--study protocol for an international COPD cohort study.

Siebeling L, ter Riet G, van der Wal WM, Geskus RB, Zoller M, Muggensturm P, Joleska I, Puhan MA.

BMC Pulm Med. 2009 May 6;9:15.PMID: 19419546 [PubMed - indexed for MEDLINE]Related articlesFree article

Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom.

Penson DF, Albertsen PC.

Surg Oncol. 2002 Jun;11(1-2):3-11. Review.PMID: 12031863 [PubMed - indexed for MEDLINE]Related articles

[Selective application of tumor markers PSA]

Kwiatkowski M, Stieber P, Huber AR, Recker F.

Ther Umsch. 2008 Sep;65(9):493-501. Review. German. PMID: 18791963 [PubMed - indexed for MEDLINE]Related articles

p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.

Kudahetti S, Fisher G, Ambroisine L, Foster C, Reuter V, Eastham J, Møller H, Kattan MW, Cooper CS, Scardino P, Cuzick J, Berney DM.

BJU Int. 2009 Jul;104(1):20-4. Epub 2009 Feb 23.PMID: 19239456 [PubMed - indexed for MEDLINE]Related articles